Anza Therapeutics' Other Investors

Anza Therapeutics raised a round of funding on , . Investors include Kleiner Perkins Caufield & Byers.

Anza Therapeutics is developing active immunotherapies for the treatment of infectious diseases and cancer. Anza's therapeutic agents are based on its proprietary live-attenuated and Killed But Metabo…

Articles about Anza Therapeutics' Other Investors: